Location History:
- Santa Monica, CA (US) (1994 - 1996)
- Oceanside, CA (US) (1997 - 1998)
- Seattle, WA (US) (1997 - 2003)
- Bellevue, WA (US) (2001 - 2005)
Company Filing History:
10 out of 142 
2 out of 2 
1 out of 1 
Years Active: 1994-2005
Title: The Innovative Journey of Alvin Y Liu
Introduction
Alvin Y Liu, a distinguished inventor based in Oceanside, CA, has made significant contributions to the field of biotechnology. With a robust portfolio of 14 patents, his innovative work focuses on the development of chimeric antibodies, highlighting his expertise in immunology and therapeutic applications.
Latest Patents
Among his latest patents, Alvin Y Liu has developed a chimeric antibody with specificity to the human B cell surface antigen. This innovative antibody comprises a human constant region and a murine variable region, demonstrating specificity to a 35 kDA polypeptide known as Bp35 (CD20), which is expressed on the surface of human B cells. The patent details methods of production and various uses for this cutting-edge invention, underscoring its potential in therapeutic applications.
Career Highlights
Throughout his career, Alvin has worked with prominent organizations, including XOMA Corporation and Royalty Pharma Finance Trust. His contributions in these roles have further advanced the understanding and utilization of antibody technology in medical treatments.
Collaborations
Alvin Y Liu has collaborated with notable professionals in the field, including Randy R Robinson and Marc D Better. These partnerships have fostered a dynamic exchange of ideas and innovation, leading to advancements in antibody development and targeting techniques.
Conclusion
Alvin Y Liu's dedication to innovation in the realm of biotechnology is evident through his impressive patent portfolio and collaborations. His work, particularly in the development of chimeric antibodies, holds promise for future therapeutic applications that can significantly impact patient care and treatment outcomes.